Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 21, 2024

SELL
$113.33 - $163.85 $155,262 - $224,474
-1,370 Reduced 50.93%
1,320 $208,000
Q4 2022

Jan 30, 2023

SELL
$100.86 - $132.13 $18,659 - $24,444
-185 Reduced 6.43%
2,690 $348,000
Q1 2022

May 02, 2022

SELL
$63.15 - $90.42 $14,208 - $20,344
-225 Reduced 7.26%
2,875 $225,000
Q3 2021

Nov 09, 2021

SELL
$65.97 - $92.48 $9,895 - $13,872
-150 Reduced 4.62%
3,100 $287,000
Q2 2021

Aug 13, 2021

SELL
$69.38 - $86.75 $9,713 - $12,145
-140 Reduced 4.13%
3,250 $253,000
Q1 2021

May 10, 2021

SELL
$72.25 - $168.95 $10,837 - $25,342
-150 Reduced 4.24%
3,390 $253,000
Q4 2020

Feb 16, 2021

SELL
$125.56 - $178.74 $2,511 - $3,574
-20 Reduced 0.56%
3,540 $604,000
Q3 2020

Nov 16, 2020

BUY
$127.12 - $172.34 $452,547 - $613,530
3,560 New
3,560 $519,000
Q3 2020

Nov 06, 2020

SELL
$127.12 - $172.34 $452,547 - $613,530
-3,560 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$97.32 - $148.76 $346,459 - $529,585
3,560 New
3,560 $452,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Advisory Alpha, LLC Portfolio

Follow Advisory Alpha, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Alpha, LLC with notifications on news.